Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.

Autor: Obladen M; University Children's Hospital, Free University, Department of Neonatology, Berlin, FRG., Maier R, Segerer H, Grauel EL, Holland BM, Stewart G, Jorch G, Rabe H, Linderkamp O, Hoffmann HG, et. al.
Jazyk: angličtina
Zdroj: Contributions to nephrology [Contrib Nephrol] 1991; Vol. 88, pp. 314-26.
DOI: 10.1159/000419541
Databáze: MEDLINE